Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03233347 |
Title | Doxorubicin Hydrochloride, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Academic and Community Cancer Research United |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope Comprehensive Cancer Center | Duarte | California | 91010 | United States | Details | |
Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | United States | Details | |
University of Nebraska Medical Center | Omaha | Nebraska | 68198 | United States | Details | |
Hackensack University Medical Center | Hackensack | New Jersey | 07601 | United States | Details | |
Carolinas Medical Center/Levine Cancer Institute | Charlotte | North Carolina | 28203 | United States | Details | |
University of Pennsylvania/Abramson Cancer Center | Philadelphia | Pennsylvania | 19104 | United States | Details | |
Vanderbilt University/Ingram Cancer Center | Nashville | Tennessee | 37232 | United States | Details | |
M D Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
University of Washington Medical Center - Montlake | Seattle | Washington | 98195 | United States | Details |